mail
versión imprimible
 
 

Gene Therapy for Neurological Disorders

Evvnt Promotion / evvnt
Archivo
-
06.12.2021 - 09.12.2021  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 am - 5:30 pm
 
Temas de la conferencia
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/853497-0?pid=4832

Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
 

Información e inscripción:

https://go.evvnt.com/853497-1?pid=4832
Ms. Ellie Saunders
 
Categorías
Investigación clínica, Medicina General
Idioma
Inglés
Cuota del Congreso
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Health Forum GasteinCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationHelix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public Health